| | ASH: Drug Algorithm Helps Clinicians Control Blood Pressure (Site not responding. Last check: 2007-10-09) |
 | | In fact, doctors in a clinical setting who adhered to such a regimen were able to obtain the widely recommended blood pressure goal of 140/90 mm Hg or less in most patients in their clinical practice, regardless of race, using olmesartan medoxomil, a new long-acting angiotensin receptor blocker, as their base therapy. |
 | | At subsequent four-week intervals, treatment for subjects who had not attained the blood pressure goal of 130/85 mm Hg or less at each point was modified stepwise with titration of olmesartan medoxomil, addition of the diuretic hydrochlorothiazide, and titration of amlodipine. |
 | | In addition, 97.2 percent of subjects were considered responders (defined as a diastolic blood pressure of less than 90 mm Hg or a reduction in diastolic blood pressure of at least 10 mm Hg) to the olmesartan medoxomil-based regimen. |
| www.docguide.com /dg.nsf/PrintPrint/F1820D78FC2A624B85256BBE0051475C (461 words) |